---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018324"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:31:05.882490+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio regains Nasdaq minimum bid price compliance; reports $133.3M cash

## Summary
- Received Nasdaq compliance letter confirming regained bid price requirement; matter closed as of Oct 15, 2025.
- Cash and cash equivalents approx. $133.3 million as of Oct 15, 2025.
- Outstanding common shares: 133,002,572; pre-funded warrants for 73,271,424 shares.
- No other material corporate updates provided in the filing.

## SEC filing metadata
- accession: 0001493152-25-018324
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315225018324/0001493152-25-018324-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315225018324/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018324
- JSON: https://secwatch.observer/filing/0001493152-25-018324.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018324.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.